CRISABOROLE

CRISABOROLE was reported 9605 times

CRISABOROLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE JOINT SWELLING 1 0.2000
1 ADMINISTRATION SITE PUSTULE 1 0.1111
2 ECZEMA INFANTILE 10 0.1042
3 NOTALGIA PARAESTHETICA 2 0.0952
4 URTICARIA CONTACT 3 0.0833
5 ADMINISTRATION SITE PARAESTHESIA 1 0.0667
6 APPLICATION SITE PAIN 1417 0.0643
7 TENDINOUS CONTRACTURE 7 0.0614
8 ERYTHRASMA 1 0.0370
9 APPLICATION SITE FISSURE 3 0.0333
10 BENZODIAZEPINE DRUG LEVEL 1 0.0333
11 APPLICATION SITE HYPERAESTHESIA 3 0.0303
12 EYELID IRRITATION 72 0.0287
13 ATOPIC KERATOCONJUNCTIVITIS 1 0.0286
14 MERALGIA PARAESTHETICA 5 0.0237
15 AUDITORY NERVE DISORDER 1 0.0227
16 EXPOSURE VIA EYE CONTACT 9 0.0214
17 APPLICATION SITE INFLAMMATION 28 0.0202
18 CELLULITE 6 0.0184
19 APPLICATION SITE INDURATION 3 0.0176
20 APPLICATION SITE PARAESTHESIA 23 0.0176
21 SCABIES 3 0.0175
22 BRAIN LOBECTOMY 1 0.0169
23 EXPOSURE VIA MUCOSA 1 0.0167
24 ADMINISTRATION SITE DISCOLOURATION 2 0.0160
25 APPLICATION SITE SWELLING 78 0.0156
26 CIRCUMORAL SWELLING 2 0.0156
27 ECZEMA WEEPING 2 0.0153
28 ECZEMA INFECTED 4 0.0149
29 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
30 LICHENIFICATION 6 0.0146
31 BURNING SENSATION 987 0.0141
32 COELIAC ARTERY COMPRESSION SYNDROME 1 0.0133
33 APPLICATION SITE WARMTH 17 0.0133
34 ACTINIC ELASTOSIS 1 0.0132
35 MALABSORPTION FROM APPLICATION SITE 2 0.0131
36 APPLICATION SITE BURN 62 0.0126
37 APPLICATION SITE COLDNESS 1 0.0118
38 HAND DERMATITIS 8 0.0115
39 APPLICATION SITE ECZEMA 1 0.0115
40 ADMINISTRATION SITE INFLAMMATION 1 0.0111
41 EYELID PAIN 22 0.0108
42 APPLICATION SITE URTICARIA 22 0.0098
43 CORNEAL OPERATION 1 0.0097
44 LEPROSY 2 0.0096
45 ECZEMA 469 0.0090
46 APPLICATION SITE ERYTHEMA 234 0.0089
47 PERIORBITAL IRRITATION 3 0.0088
48 DERMATITIS ATOPIC 455 0.0086
49 APPLICATION SITE HYPOAESTHESIA 2 0.0085
50 DERMATOPHYTOSIS OF NAIL 1 0.0084
51 SKIN HYPOPIGMENTATION 14 0.0079
52 APPLICATION SITE DISCOLOURATION 32 0.0079
53 APPLICATION SITE INFECTION 4 0.0079
54 CERVIX CARCINOMA STAGE III 1 0.0076
55 ACARODERMATITIS 8 0.0073
56 APPLICATION SITE NODULE 1 0.0073
57 ECZEMA EYELIDS 4 0.0071
58 CHRONIC SPONTANEOUS URTICARIA 8 0.0069
59 POST INFLAMMATORY PIGMENTATION CHANGE 3 0.0066
60 APPLICATION SITE HYPERSENSITIVITY 8 0.0066
61 DIAGNOSTIC PROCEDURE 1 0.0066
62 ABDOMINAL WALL WOUND 1 0.0065
63 PERIORAL DERMATITIS 4 0.0063
64 APPLICATION SITE OEDEMA 2 0.0062
65 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 44 0.0061
66 APPLICATION SITE ACNE 3 0.0061
67 APPLICATION SITE PRURITUS 139 0.0061
68 APPLICATION SITE WOUND 1 0.0061
69 ALLERGIC SINUSITIS 5 0.0058
70 EYELID BLEEDING 1 0.0058
71 MOLLUSCUM CONTAGIOSUM 3 0.0056
72 SHOULDER FRACTURE 9 0.0055
73 APPLICATION SITE PUSTULES 2 0.0055
74 APPLICATION SITE HAEMATOMA 1 0.0055
75 APPLICATION SITE EXFOLIATION 22 0.0053
76 SENSITIVITY TO WEATHER CHANGE 28 0.0053
77 APPLICATION SITE DISCHARGE 6 0.0052
78 SKIN DEPIGMENTATION 7 0.0051
79 DERMATITIS 107 0.0051
80 SKIN WEEPING 18 0.0050
81 ALLERGIC REACTION TO EXCIPIENT 10 0.0050
82 LIP ERYTHEMA 4 0.0050
83 APPLICATION SITE DRYNESS 17 0.0050
84 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 85 0.0050
85 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 145 0.0049
86 ARTHRODESIS 5 0.0049
87 SKIN FISSURES 95 0.0049
88 APPLICATION SITE LACERATION 2 0.0048
89 HAND-FOOT-AND-MOUTH DISEASE 4 0.0048
90 SKIN DISCOMFORT 13 0.0048
91 AXILLARY PAIN 7 0.0047
92 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
93 EXPOSURE TO FUNGUS 1 0.0047
94 SCRATCH 49 0.0046
95 HAEMANGIOMA OF SKIN 2 0.0046
96 SKIN LAXITY 2 0.0046
97 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 243 0.0044
98 SKIN HAEMORRHAGE 65 0.0044
99 ECZEMA HERPETICUM 2 0.0043
100 APPLICATION SITE VESICLES 28 0.0043
101 EHLERS-DANLOS SYNDROME 2 0.0043
102 APPLICATION SITE IRRITATION 53 0.0043
103 FACIAL DISCOMFORT 3 0.0042
104 SKIN DISORDER 140 0.0042
105 SEBORRHOEIC KERATOSIS 6 0.0041
106 CHEILITIS 22 0.0041
107 EVANS SYNDROME 2 0.0041
108 LENTIGO 2 0.0040
109 GENITAL ERYTHEMA 2 0.0040
110 IMPETIGO 6 0.0040
111 DERMATITIS INFECTED 2 0.0040
112 ABORTION THREATENED 2 0.0040
113 REBOUND ECZEMA 8 0.0039
114 APPLICATION SITE DISCOMFORT 7 0.0039
115 ADENOIDAL DISORDER 1 0.0038
116 WHITE BLOOD CELLS URINE POSITIVE 7 0.0037
117 NEUROGENIC SHOCK 2 0.0037
118 APPLICATION SITE MASS 1 0.0036
119 SEROSITIS 2 0.0036
120 GENITAL DISCOMFORT 2 0.0036
121 ANDROGENETIC ALOPECIA 1 0.0035
122 LIP PRURITUS 3 0.0035
123 ADMINISTRATION SITE PAIN 4 0.0035
124 EAR INFLAMMATION 1 0.0035
125 EYE INFECTION STAPHYLOCOCCAL 1 0.0035
126 SINUS PAIN 8 0.0034
127 SKIN EROSION 11 0.0034
128 APPLICATION SITE RASH 45 0.0033
129 SKIN BURNING SENSATION 234 0.0033
130 PRODUCT PHYSICAL CONSISTENCY ISSUE 18 0.0032
131 THERMAL BURN 23 0.0032
132 SKIN TEXTURE ABNORMAL 3 0.0031
133 SKIN ATROPHY 18 0.0031
134 EYE INFECTION VIRAL 1 0.0031
135 THERAPEUTIC PRODUCT INEFFECTIVE 12 0.0031
136 ADMINISTRATION SITE SWELLING 1 0.0031
137 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 219 0.0031
138 EYELID RASH 3 0.0031
139 REACTION TO EXCIPIENT 7 0.0030
140 FACIAL PAIN 27 0.0030
141 SKIN INJURY 10 0.0030
142 REBOUND ATOPIC DERMATITIS 6 0.0030
143 BLOOD VISCOSITY DECREASED 1 0.0030
144 SCAB 34 0.0030
145 BENIGN NEOPLASM OF SKIN 1 0.0030
146 SHOULDER ARTHROPLASTY 8 0.0030
147 ECTROPION 1 0.0030
148 CONJUNCTIVITIS BACTERIAL 1 0.0029
149 OPHTHALMIC MIGRAINE 2 0.0029
150 SKIN HYPERTROPHY 8 0.0028
151 DYSHIDROTIC ECZEMA 2 0.0028
152 CHEMICAL BURN OF SKIN 7 0.0028
153 SUPERFICIAL INJURY OF EYE 3 0.0027
154 BLEPHARITIS 11 0.0027
155 SEBORRHOEA 10 0.0027
156 DERMATITIS CONTACT 31 0.0027
157 CONJUNCTIVITIS ALLERGIC 4 0.0027
158 NEURODERMATITIS 10 0.0027
159 CHEMICAL BURN 3 0.0026
160 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
161 CHAPPED LIPS 11 0.0025
162 EYELID EXFOLIATION 2 0.0025
163 EYELID SKIN DRYNESS 3 0.0025
164 DEATH OF RELATIVE 1 0.0025
165 STAPHYLOCOCCAL SKIN INFECTION 3 0.0024
166 GENITAL INFECTION FUNGAL 2 0.0024
167 NASAL PRURITUS 3 0.0024
168 SWELLING OF EYELID 15 0.0024
169 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
170 ROSACEA 11 0.0024
171 CONDITION AGGRAVATED 711 0.0023
172 SKIN IRRITATION 105 0.0023
173 EAR PRURITUS 8 0.0023
174 PIGMENTATION DISORDER 14 0.0023
175 SKIN EXFOLIATION 188 0.0022
176 SCREAMING 14 0.0022
177 APPLICATION SITE HAEMORRHAGE 6 0.0022
178 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
179 PERIORBITAL SWELLING 12 0.0021
180 SKIN ABRASION 10 0.0021
181 PARANASAL SINUS DISCOMFORT 8 0.0021
182 WRONG SCHEDULE 2 0.0021
183 LUMBAR SPINAL STENOSIS 6 0.0021
184 ECZEMA NUMMULAR 1 0.0020
185 DRY SKIN 273 0.0020
186 SKIN DISCOLOURATION 93 0.0020
187 POOR QUALITY PRODUCT ADMINISTERED 21 0.0020
188 BLEPHARAL PIGMENTATION 1 0.0020
189 BONE EROSION 7 0.0020
190 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
191 SKIN SENSITISATION 2 0.0019
192 EYE DISCHARGE 20 0.0019
193 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
194 APPLICATION SITE PAPULES 2 0.0019
195 EYE IRRITATION 108 0.0019
196 EPHELIDES 1 0.0019
197 SKIN WRINKLING 5 0.0018
198 ERYTHEMA 376 0.0018
199 DISCOMFORT 111 0.0018
200 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
201 TINEA INFECTION 2 0.0018
202 MACULE 5 0.0018
203 ORAL HERPES 35 0.0018
204 SKIN WOUND 3 0.0018
205 PRE-EXISTING CONDITION IMPROVED 11 0.0018
206 EYE PRURITUS 59 0.0018
207 SKIN HYPERPIGMENTATION 15 0.0017
208 MILIARIA 3 0.0017
209 EYE ULCER 1 0.0017
210 EYELID DISORDER 4 0.0017
211 EYELID MARGIN CRUSTING 5 0.0017
212 PRURITUS 662 0.0017
213 APPLICATION SITE REACTION 12 0.0017
214 PAPULE 12 0.0017
215 AMBLYOPIA 1 0.0017
216 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
217 COCCIDIOIDOMYCOSIS 2 0.0017
218 CONJUNCTIVITIS 31 0.0017
219 OTITIS EXTERNA 2 0.0016
220 DRUG EFFECT INCOMPLETE 59 0.0016
221 XEROSIS 2 0.0016
222 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
223 DERMATOSIS 1 0.0016
224 LIP HAEMORRHAGE 2 0.0016
225 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
226 BLADDER IRRITATION 1 0.0016
227 EYE SWELLING 58 0.0016
228 APPLICATION SITE EROSION 2 0.0016
229 CONCUSSION 12 0.0015
230 ALLERGIC OEDEMA 1 0.0015
231 IMPAIRED QUALITY OF LIFE 22 0.0015
232 PAIN OF SKIN 41 0.0015
233 TREATMENT FAILURE 126 0.0015
234 EXFOLIATIVE RASH 4 0.0015
235 WISDOM TEETH REMOVAL 2 0.0015
236 DRUG INEFFECTIVE 1995 0.0015
237 LIP EXFOLIATION 2 0.0015
238 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
239 CUTANEOUS SYMPTOM 1 0.0015
240 RASH 622 0.0014
241 FALSE NEGATIVE INVESTIGATION RESULT 1 0.0014
242 APPLICATION SITE ULCER 1 0.0014
243 ABDOMINAL TENDERNESS 7 0.0014
244 LIP PAIN 4 0.0014
245 SKIN SWELLING 12 0.0014
246 PRODUCT USE IN UNAPPROVED INDICATION 341 0.0014
247 OCULAR HYPERAEMIA 65 0.0014
248 MELANOCYTIC NAEVUS 6 0.0014
249 SLEEP PARALYSIS 2 0.0014
250 GENERALISED ANXIETY DISORDER 2 0.0014
251 DARK CIRCLES UNDER EYES 2 0.0014
252 ANKLE FRACTURE 21 0.0014
253 BLISTER RUPTURE 1 0.0013
254 RASH MACULAR 47 0.0013
255 ASTIGMATISM 2 0.0013
256 INJECTION SITE PARAESTHESIA 2 0.0013
257 EYE ALLERGY 2 0.0013
258 EYELIDS PRURITUS 4 0.0013
259 SKIN TIGHTNESS 6 0.0013
260 PUSTULE 3 0.0013
261 BLISTER 71 0.0013
262 FEAR OF INJECTION 9 0.0013
263 THERAPEUTIC RESPONSE SHORTENED 41 0.0012
264 RASH ERYTHEMATOUS 59 0.0012
265 SLEEP DISORDER 87 0.0012
266 FEAR OF FALLING 1 0.0012
267 ACNE PUSTULAR 1 0.0012
268 SENSITIVE SKIN 9 0.0012
269 SUSPECTED COVID-19 4 0.0012
270 SKIN LESION 33 0.0012
271 ARTHROPOD STING 2 0.0012
272 DRY EYE 60 0.0012
273 SEASONAL ALLERGY 17 0.0012
274 TONSILLAR HYPERTROPHY 2 0.0012
275 DERMATOMYOSITIS 3 0.0012
276 CAROTID ARTERY THROMBOSIS 1 0.0012
277 PLEURISY 7 0.0012
278 JOINT EFFUSION 8 0.0012
279 SKIN INFECTION 13 0.0012
280 INFUSION SITE DISCHARGE 2 0.0011
281 BURNS SECOND DEGREE 2 0.0011
282 RHINITIS ALLERGIC 5 0.0011
283 RASH PAPULAR 25 0.0011
284 BLOOD MAGNESIUM INCREASED 1 0.0011
285 ERYTHEMA OF EYELID 6 0.0011
286 BONE CONTUSION 1 0.0011
287 NERVE COMPRESSION 10 0.0011
288 POOR QUALITY DRUG ADMINISTERED 7 0.0011
289 PRODUCT USE ISSUE 203 0.0011
290 ACCIDENTAL DEATH 2 0.0011
291 APPLICATION SITE DERMATITIS 1 0.0011
292 TUNNEL VISION 2 0.0011
293 BONE CYST 1 0.0011
294 PRODUCT DOSE OMISSION IN ERROR 30 0.0011
295 APPETITE DISORDER 7 0.0011
296 EXPOSURE VIA DIRECT CONTACT 1 0.0011
297 JOINT DISLOCATION 11 0.0010
298 INTENTIONAL PRODUCT MISUSE 91 0.0010
299 FOOD ALLERGY 8 0.0010
300 DERMATITIS ALLERGIC 13 0.0010
301 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
302 SKIN WARM 6 0.0010
303 APPLICATION SITE BRUISE 1 0.0010
304 ANIMAL SCRATCH 1 0.0010
305 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
306 CRYING 37 0.0010
307 SKIN LACERATION 11 0.0010
308 FRUSTRATION TOLERANCE DECREASED 8 0.0010
309 BUTTERFLY RASH 1 0.0010
310 HYPERAESTHESIA 8 0.0010
311 EYE DISORDER 32 0.0010
312 BREAST DISCOMFORT 1 0.0010
313 BURNS THIRD DEGREE 1 0.0009
314 SUNBURN 7 0.0009
315 ORAL DISCOMFORT 13 0.0009
316 TEARFULNESS 4 0.0009
317 WRIST FRACTURE 11 0.0009
318 CLAUSTROPHOBIA 1 0.0009
319 LIMB MASS 2 0.0009
320 OTITIS MEDIA 3 0.0009
321 SKIN MASS 6 0.0009
322 URTICARIA 150 0.0009
323 DRUG EFFECT VARIABLE 1 0.0009
324 PERIARTHRITIS 2 0.0009
325 NEUTROPHILIA 5 0.0009
326 BRAIN OPERATION 2 0.0009
327 DYSLEXIA 1 0.0009
328 OFF LABEL USE 759 0.0009
329 PAIN 530 0.0009
330 MYOPIA 2 0.0008
331 EYE INFLAMMATION 8 0.0008
332 BRONCHIAL HYPERREACTIVITY 1 0.0008
333 BLADDER PROLAPSE 1 0.0008
334 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 15 0.0008
335 RASH PRURITIC 44 0.0008
336 WOUND HAEMORRHAGE 3 0.0008
337 FOOT OPERATION 4 0.0008
338 PENIS DISORDER 2 0.0008
339 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
340 ALLERGY TO CHEMICALS 1 0.0008
341 THERAPEUTIC RESPONSE UNEXPECTED 36 0.0008
342 APPLICATION SITE SCAR 1 0.0008
343 AUTOIMMUNE THYROIDITIS 3 0.0008
344 EXPOSURE VIA INGESTION 2 0.0008
345 VULVOVAGINAL PRURITUS 4 0.0008
346 EXCORIATION 2 0.0008
347 HYPERSENSITIVITY 146 0.0008
348 SWELLING FACE 51 0.0008
349 ENTERITIS 5 0.0008
350 WOUND SECRETION 3 0.0008
351 THERAPEUTIC RESPONSE DECREASED 46 0.0008
352 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
353 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
354 JOINT RANGE OF MOTION DECREASED 10 0.0007
355 BODY MASS INDEX INCREASED 1 0.0007
356 SINUS CONGESTION 10 0.0007
357 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
358 FOOT FRACTURE 14 0.0007
359 IMMUNODEFICIENCY 11 0.0007
360 INFLAMMATION 38 0.0007
361 INVASIVE DUCTAL BREAST CARCINOMA 2 0.0007
362 TRIGGER FINGER 3 0.0007
363 ORAL FUNGAL INFECTION 2 0.0007
364 LACRIMATION INCREASED 22 0.0007
365 PHOTOSENSITIVITY REACTION 12 0.0007
366 ONYCHOCLASIS 5 0.0007
367 HYPERKERATOSIS 4 0.0007
368 DRUG SCREEN FALSE POSITIVE 2 0.0007
369 STREPTOCOCCAL INFECTION 4 0.0007
370 SERUM SICKNESS 2 0.0007
371 SWELLING 67 0.0007
372 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
373 EYE PAIN 40 0.0007
374 INTENTIONAL DOSE OMISSION 20 0.0007
375 HORDEOLUM 3 0.0007
376 EXPIRED PRODUCT ADMINISTERED 23 0.0007
377 MADAROSIS 8 0.0007
378 HAND DEFORMITY 9 0.0007
379 NAIL DISORDER 6 0.0007
380 IMMUNOSUPPRESSION 6 0.0007
381 LOWER LIMB FRACTURE 13 0.0007
382 CEREBRAL DISORDER 5 0.0007
383 TOOTH DISORDER 15 0.0007
384 CREPITATIONS 2 0.0007
385 WEIGHT FLUCTUATION 7 0.0007
386 SUSPECTED OFF LABEL USE 3 0.0007
387 ADHESION 1 0.0007
388 DRUG EFFECT DELAYED 3 0.0007
389 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
390 PHARYNGITIS STREPTOCOCCAL 7 0.0006
391 BLOOD BLISTER 2 0.0006
392 BACTERIAL VAGINOSIS 1 0.0006
393 BREAST CANCER RECURRENT 2 0.0006
394 PRODUCT PRESCRIBING ERROR 15 0.0006
395 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
396 CYSTITIS INTERSTITIAL 1 0.0006
397 ILLNESS 64 0.0006
398 EYE INFECTION 7 0.0006
399 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
400 DENTAL IMPLANTATION 1 0.0006
401 PRODUCT FORMULATION ISSUE 4 0.0006
402 PLANTAR FASCIITIS 2 0.0006
403 SKIN PLAQUE 5 0.0006
404 LIMB INJURY 16 0.0006
405 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
406 WOUND COMPLICATION 2 0.0006
407 ACUTE SINUSITIS 1 0.0006
408 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
409 HAIR GROWTH ABNORMAL 4 0.0006
410 TENDON RUPTURE 7 0.0006
411 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
412 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
413 LIP DRY 5 0.0005
414 LIMB DISCOMFORT 17 0.0005
415 ESSENTIAL HYPERTENSION 1 0.0005
416 AUTISM SPECTRUM DISORDER 3 0.0005
417 DEAFNESS UNILATERAL 3 0.0005
418 BODY TEMPERATURE ABNORMAL 1 0.0005
419 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
420 DIFFUSE ALOPECIA 1 0.0005
421 OCULAR DISCOMFORT 6 0.0005
422 THROAT CLEARING 2 0.0005
423 REBOUND EFFECT 6 0.0005
424 FACE INJURY 2 0.0005
425 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
426 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
427 DEVICE USE ISSUE 9 0.0005
428 ATROPHY 1 0.0005
429 PSORIASIS 67 0.0005
430 ORAL INFECTION 2 0.0005
431 TOOTHACHE 9 0.0005
432 INJECTION SITE VESICLES 3 0.0005
433 PRODUCT PHYSICAL ISSUE 10 0.0005
434 INITIAL INSOMNIA 5 0.0005
435 EAR DISCOMFORT 5 0.0005
436 ANAL PRURITUS 1 0.0005
437 INFUSION SITE EXTRAVASATION 3 0.0005
438 FOLLICULITIS 5 0.0005
439 INJECTION SITE DISCOMFORT 5 0.0005
440 EAR SWELLING 1 0.0005
441 PRODUCT DISPENSING ISSUE 2 0.0005
442 SCAR 8 0.0005
443 WOUND 13 0.0005
444 EXOPHTHALMOS 1 0.0005
445 MUSCULOSKELETAL DISCOMFORT 8 0.0005
446 POOR QUALITY SLEEP 10 0.0005
447 HEPATIC LESION 2 0.0005
448 HERPES SIMPLEX 3 0.0005
449 IMMUNE SYSTEM DISORDER 6 0.0005
450 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
451 ACCIDENT AT WORK 1 0.0005
452 ASTHMA 51 0.0005
453 EAR INFECTION 12 0.0005
454 CORNEAL OEDEMA 1 0.0004
455 WRONG PRODUCT ADMINISTERED 3 0.0004
456 INJECTION SITE SWELLING 34 0.0004
457 HYPOACUSIS 19 0.0004
458 RESPIRATORY TRACT CONGESTION 7 0.0004
459 ULCER 7 0.0004
460 URINE ABNORMALITY 2 0.0004
461 ACNE 33 0.0004
462 LYMPHOEDEMA 3 0.0004
463 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
464 PRODUCT DISTRIBUTION ISSUE 4 0.0004
465 DISCOURAGEMENT 1 0.0004
466 YELLOW SKIN 2 0.0004
467 SKIN REACTION 6 0.0004
468 NASAL CONGESTION 25 0.0004
469 CONTRAST MEDIA REACTION 1 0.0004
470 PRODUCT DOSE OMISSION ISSUE 124 0.0004
471 INJECTION SITE REACTION 29 0.0004
472 MACULAR DEGENERATION 5 0.0004
473 PERICARDITIS 7 0.0004
474 TONGUE DISORDER 3 0.0004
475 RASH VESICULAR 2 0.0004
476 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
477 RASH PUSTULAR 3 0.0004
478 KNEE OPERATION 4 0.0004
479 DENTAL OPERATION 1 0.0004
480 INJECTION SITE INFLAMMATION 2 0.0004
481 DERMATITIS EXFOLIATIVE 2 0.0004
482 DISEASE RECURRENCE 19 0.0004
483 BRAIN INJURY 4 0.0004
484 LYMPHADENOPATHY 14 0.0004
485 BODY TEMPERATURE INCREASED 8 0.0004
486 ABNORMAL UTERINE BLEEDING 1 0.0004
487 GASTROENTERITIS VIRAL 7 0.0004
488 ACTINIC KERATOSIS 1 0.0004
489 PERIORBITAL OEDEMA 2 0.0004
490 DRUG INTOLERANCE 37 0.0004
491 HERPES ZOSTER 22 0.0004
492 MULTIPLE ALLERGIES 3 0.0004
493 INJECTION SITE MASS 14 0.0004
494 MIDDLE INSOMNIA 7 0.0004
495 OVERWEIGHT 2 0.0004
496 PHOTOPHOBIA 7 0.0004
497 BRUXISM 2 0.0004
498 COVID-19 65 0.0004
499 NEURALGIA 9 0.0004
500 HIP SURGERY 2 0.0004
501 PRODUCT DISPENSING ERROR 8 0.0004
502 PRODUCT PRESCRIBING ISSUE 8 0.0004
503 INJECTION SITE URTICARIA 9 0.0004
504 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
505 ASTHENOPIA 2 0.0004
506 GLAUCOMA 7 0.0004
507 EOSINOPHILIC OESOPHAGITIS 1 0.0004
508 PERIPHERAL SWELLING 55 0.0004
509 PRODUCT COMPLAINT 9 0.0004
510 BREAST CANCER STAGE IV 1 0.0004
511 BLOOD PRESSURE ABNORMAL 7 0.0004
512 IMPAIRED DRIVING ABILITY 4 0.0004
513 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
514 CARDIAC OPERATION 3 0.0003
515 RASH GENERALISED 9 0.0003
516 EXERCISE TOLERANCE DECREASED 2 0.0003
517 EYELID OEDEMA 4 0.0003
518 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
519 INJECTION SITE PAIN 102 0.0003
520 KNEE ARTHROPLASTY 7 0.0003
521 LIP SWELLING 11 0.0003
522 JOINT INJURY 7 0.0003
523 INSURANCE ISSUE 5 0.0003
524 SMALL INTESTINAL OBSTRUCTION 4 0.0003
525 SPINAL OPERATION 4 0.0003
526 SCOLIOSIS 2 0.0003
527 PSORIATIC ARTHROPATHY 13 0.0003
528 SECRETION DISCHARGE 4 0.0003
529 BLINDNESS 13 0.0003
530 PARAESTHESIA 50 0.0003
531 PRODUCT USE COMPLAINT 5 0.0003
532 MUSCULOSKELETAL DISORDER 6 0.0003
533 INJECTION SITE IRRITATION 4 0.0003
534 THERAPY NON-RESPONDER 14 0.0003
535 CARDIAC FLUTTER 2 0.0003
536 AUTOIMMUNE DISORDER 3 0.0003
537 PHARYNGEAL SWELLING 3 0.0003
538 PRODUCT DOSE OMISSION 20 0.0003
539 HAEMORRHAGE 32 0.0003
540 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
541 TOOTH INFECTION 4 0.0003
542 SINUS DISORDER 6 0.0003
543 SARS-COV-2 TEST POSITIVE 4 0.0003
544 QUALITY OF LIFE DECREASED 4 0.0003
545 CELLULITIS 15 0.0003
546 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 53 0.0003
547 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
548 LOCALISED INFECTION 7 0.0003
549 TENDERNESS 3 0.0003
550 FORMICATION 2 0.0003
551 INFECTION 41 0.0003
552 SINUSITIS 29 0.0003
553 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
554 APPENDICECTOMY 1 0.0003
555 PRODUCT STORAGE ERROR 24 0.0003
556 CAROTID ARTERY OCCLUSION 1 0.0003
557 ORAL DISORDER 2 0.0003
558 TOOTH FRACTURE 3 0.0003
559 DENTAL CARIES 3 0.0003
560 ARTHROPOD BITE 2 0.0003
561 ARTHROPATHY 15 0.0003
562 NERVE INJURY 3 0.0003
563 GENERAL SYMPTOM 2 0.0003
564 TENDON PAIN 2 0.0003
565 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
566 BOWEL MOVEMENT IRREGULARITY 2 0.0003
567 INJECTION SITE RASH 8 0.0003
568 APHTHOUS ULCER 2 0.0003
569 EAR PAIN 5 0.0003
570 THERAPY PARTIAL RESPONDER 4 0.0003
571 CERVIX CARCINOMA 1 0.0003
572 DRUG-INDUCED LIVER INJURY 8 0.0003
573 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
574 FURUNCLE 2 0.0003
575 EXPOSURE VIA BREAST MILK 1 0.0003
576 HEPATIC ENZYME INCREASED 17 0.0002
577 DIABETES MELLITUS 19 0.0002
578 SENSORY DISTURBANCE 4 0.0002
579 RHINITIS 2 0.0002
580 PRODUCT ADMINISTRATION ERROR 5 0.0002
581 BACK DISORDER 4 0.0002
582 POST PROCEDURAL INFECTION 2 0.0002
583 VISUAL IMPAIRMENT 30 0.0002
584 PHARYNGITIS 3 0.0002
585 MENSTRUAL DISORDER 2 0.0002
586 VIRAL INFECTION 8 0.0002
587 EOSINOPHIL COUNT INCREASED 2 0.0002
588 GLYCOSYLATED HAEMOGLOBIN INCREASED 6 0.0002
589 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
590 SENSATION OF FOREIGN BODY 2 0.0002
591 INFUSION SITE ERYTHEMA 2 0.0002
592 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
593 INTRAOCULAR PRESSURE INCREASED 3 0.0002
594 VITAMIN D DECREASED 2 0.0002
595 INFLUENZA 26 0.0002
596 ABNORMAL SENSATION IN EYE 1 0.0002
597 SKIN CANCER 5 0.0002
598 PRURITUS GENERALISED 5 0.0002
599 HYSTERECTOMY 2 0.0002
600 PRODUCTIVE COUGH 11 0.0002
601 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
602 PAIN IN EXTREMITY 67 0.0002
603 PURPURA 2 0.0002
604 EXPOSURE DURING PREGNANCY 14 0.0002
605 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
606 GASTROINTESTINAL INFECTION 2 0.0002
607 SNEEZING 5 0.0002
608 OROPHARYNGEAL DISCOMFORT 2 0.0002
609 HIDRADENITIS 2 0.0002
610 CONTUSION 21 0.0002
611 DYSPAREUNIA 1 0.0002
612 FEELING OF DESPAIR 1 0.0002
613 STAPHYLOCOCCAL INFECTION 7 0.0002
614 BLOOD PROLACTIN INCREASED 1 0.0002
615 SPINAL DISORDER 2 0.0002
616 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
617 PRODUCT PACKAGING ISSUE 2 0.0002
618 SLEEP APNOEA SYNDROME 4 0.0002
619 HYPOKINESIA 3 0.0002
620 NASOPHARYNGITIS 38 0.0002
621 FIBROMYALGIA 5 0.0002
622 GASTROENTERITIS 3 0.0002
623 THROMBOTIC MICROANGIOPATHY 2 0.0002
624 VITAMIN D DEFICIENCY 2 0.0002
625 LIGAMENT SPRAIN 2 0.0002
626 EMBEDDED DEVICE 2 0.0002
627 RHINORRHOEA 13 0.0002
628 FEELING ABNORMAL 48 0.0002
629 OVARIAN CYST 2 0.0002
630 SALIVARY HYPERSECRETION 2 0.0002
631 ERYSIPELAS 1 0.0002
632 CORONARY ARTERIAL STENT INSERTION 1 0.0002
633 DRY THROAT 2 0.0002
634 TOOTH ABSCESS 2 0.0002
635 FEELING HOT 12 0.0002
636 PHARYNGEAL OEDEMA 3 0.0002
637 PRODUCT PREPARATION ERROR 4 0.0002
638 TEMPERATURE INTOLERANCE 2 0.0002
639 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
640 INJECTION SITE ERYTHEMA 24 0.0002
641 EXPOSURE VIA SKIN CONTACT 5 0.0002
642 C-REACTIVE PROTEIN INCREASED 7 0.0002
643 BASAL CELL CARCINOMA 3 0.0002
644 SWOLLEN TONGUE 6 0.0002
645 PRODUCT ODOUR ABNORMAL 2 0.0002
646 ABDOMINAL DISCOMFORT 32 0.0002
647 MIGRAINE 18 0.0002
648 ANORECTAL DISCOMFORT 1 0.0002
649 EATING DISORDER 4 0.0002
650 COMPRESSION FRACTURE 1 0.0002
651 BEHAVIOUR DISORDER 1 0.0002
652 MENTAL DISORDER 8 0.0002
653 OROPHARYNGEAL PAIN 17 0.0002
654 OESOPHAGITIS 2 0.0002
655 IMPAIRED HEALING 6 0.0002
656 ANAPHYLACTIC REACTION 10 0.0002
657 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
658 FOOT DEFORMITY 2 0.0002
659 FUNGAL INFECTION 6 0.0002
660 INJECTION SITE PRURITUS 12 0.0002
661 DEMENTIA 5 0.0002
662 ORAL PAIN 4 0.0002
663 ALOPECIA 35 0.0002
664 MICTURITION URGENCY 2 0.0002
665 MYOCARDITIS 2 0.0002
666 HYPERSOMNIA 5 0.0002
667 MUSCULOSKELETAL STIFFNESS 15 0.0002
668 SPLENOMEGALY 2 0.0002
669 SURGERY 10 0.0002
670 DEPRESSED MOOD 9 0.0002
671 ENERGY INCREASED 1 0.0002
672 GALLBLADDER DISORDER 3 0.0002
673 CARDIAC PACEMAKER INSERTION 1 0.0002
674 VISION BLURRED 23 0.0002
675 ACCIDENT 2 0.0002
676 HYPERLIPIDAEMIA 2 0.0002
677 ROAD TRAFFIC ACCIDENT 7 0.0002
678 MULTIPLE SCLEROSIS 8 0.0002
679 DRUG EFFECT DECREASED 9 0.0002
680 THYROID CANCER 2 0.0002
681 OSTEOMYELITIS 3 0.0002
682 HEPATITIS C 2 0.0002
683 NEOPLASM MALIGNANT 11 0.0002
684 DERMATITIS ACNEIFORM 1 0.0002
685 CYST 2 0.0002
686 HAIR COLOUR CHANGES 2 0.0002
687 ARTHRALGIA 66 0.0002
688 INSOMNIA 42 0.0002
689 GAIT DISTURBANCE 30 0.0002
690 MYDRIASIS 2 0.0002
691 INFUSION SITE PAIN 2 0.0002
692 SKIN ULCER 4 0.0002
693 RESPIRATORY TRACT INFECTION 4 0.0002
694 NODULE 2 0.0002
695 MEMORY IMPAIRMENT 21 0.0002
696 SPEECH DISORDER 8 0.0002
697 URINARY TRACT INFECTION 26 0.0002
698 INCORRECT PRODUCT STORAGE 2 0.0002
699 BEDRIDDEN 2 0.0002
700 ANKYLOSING SPONDYLITIS 2 0.0002
701 CORONAVIRUS INFECTION 1 0.0002
702 DYSMENORRHOEA 2 0.0002
703 ADVERSE REACTION 2 0.0002
704 UPPER LIMB FRACTURE 3 0.0002
705 INJECTION SITE BRUISING 12 0.0002
706 EYE HAEMORRHAGE 2 0.0001
707 GAIT INABILITY 5 0.0001
708 BREAST MASS 1 0.0001
709 STOMATITIS 9 0.0001
710 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
711 THROAT TIGHTNESS 4 0.0001
712 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
713 EPISTAXIS 11 0.0001
714 IMPAIRED GASTRIC EMPTYING 2 0.0001
715 GASTROINTESTINAL DISORDER 13 0.0001
716 NIGHTMARE 5 0.0001
717 EXTRASYSTOLES 1 0.0001
718 MASS 2 0.0001
719 BLINDNESS UNILATERAL 2 0.0001
720 SINUS TACHYCARDIA 2 0.0001
721 RETCHING 3 0.0001
722 IRRITABLE BOWEL SYNDROME 3 0.0001
723 ARTHRITIS 11 0.0001
724 PARAESTHESIA ORAL 2 0.0001
725 TREMOR 23 0.0001
726 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
727 THERAPY CESSATION 7 0.0001
728 COLON CANCER 2 0.0001
729 PULMONARY OEDEMA 6 0.0001
730 RESPIRATORY DISORDER 4 0.0001
731 HYPOAESTHESIA 20 0.0001
732 CHROMATURIA 3 0.0001
733 HOT FLUSH 10 0.0001
734 NO ADVERSE EVENT 24 0.0001
735 ECONOMIC PROBLEM 2 0.0001
736 PLEURAL EFFUSION 8 0.0001
737 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
738 MUSCLE TWITCHING 3 0.0001
739 EMOTIONAL DISORDER 4 0.0001
740 LYMPHOMA 2 0.0001
741 CHILLS 15 0.0001
742 BRAIN FOG 2 0.0001
743 AFFECTIVE DISORDER 1 0.0001
744 INCORRECT DOSE ADMINISTERED 29 0.0001
745 PNEUMOTHORAX 2 0.0001
746 SCIATICA 2 0.0001
747 ATRIAL FLUTTER 1 0.0001
748 NECK PAIN 7 0.0001
749 BLOOD DISORDER 1 0.0001
750 MOVEMENT DISORDER 4 0.0001
751 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
752 MENTAL IMPAIRMENT 3 0.0001
753 DECUBITUS ULCER 1 0.0001
754 BRONCHITIS 9 0.0001
755 COUGH 34 0.0001
756 HEART RATE INCREASED 12 0.0001
757 WEIGHT INCREASED 27 0.0001
758 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
759 FALL 40 0.0001
760 POLLAKIURIA 5 0.0001
761 DYSPHONIA 7 0.0001
762 TYPE 2 DIABETES MELLITUS 4 0.0001
763 CATARACT 7 0.0001
764 GASTRIC DISORDER 4 0.0001
765 HYPERHIDROSIS 15 0.0001
766 IRRITABILITY 7 0.0001
767 PYREXIA 40 0.0001
768 DEAFNESS 3 0.0001
769 JOINT STIFFNESS 3 0.0001
770 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
771 ANGIOEDEMA 5 0.0001
772 DRUG ERUPTION 2 0.0001
773 THIRST 2 0.0001
774 GOUT 2 0.0001
775 ANAL INCONTINENCE 1 0.0001
776 COMPLICATION OF DEVICE REMOVAL 2 0.0001
777 MOOD ALTERED 3 0.0001
778 RESTLESS LEGS SYNDROME 2 0.0001
779 END STAGE RENAL DISEASE 2 0.0001
780 EXOSTOSIS 1 0.0001
781 TINNITUS 5 0.0001
782 DIVERTICULITIS 3 0.0001
783 HEPATIC STEATOSIS 2 0.0001
784 BACTERIAL INFECTION 2 0.0001
785 ARTERIOSCLEROSIS 1 0.0001
786 UNEVALUABLE EVENT 8 0.0001
787 ABDOMINAL DISTENSION 11 0.0001
788 PROTEINURIA 2 0.0001
789 LETHARGY 6 0.0001
790 DRUG PRESCRIBING ERROR 2 0.0001
791 ACUTE RESPIRATORY FAILURE 2 0.0001
792 MALAISE 45 0.0001
793 COELIAC DISEASE 1 0.0001
794 KIDNEY INFECTION 2 0.0001
795 WHEEZING 6 0.0001
796 EMPHYSEMA 1 0.0001
797 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
798 ILL-DEFINED DISORDER 6 0.0001
799 EXTRA DOSE ADMINISTERED 4 0.0001
800 ANXIETY 28 0.0001
801 EPILEPSY 3 0.0001
802 CHEST DISCOMFORT 10 0.0001
803 HEADACHE 61 0.0001
804 FEMUR FRACTURE 3 0.0001
805 PRODUCT QUALITY ISSUE 13 0.0001
806 MOUTH ULCERATION 2 0.0001
807 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
808 OSTEOARTHRITIS 4 0.0001
809 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
810 CYSTITIS 3 0.0001
811 HYPOTHYROIDISM 3 0.0001
812 BODY HEIGHT DECREASED 1 0.0001
813 DECREASED ACTIVITY 1 0.0001
814 OEDEMA 5 0.0001
815 BIPOLAR DISORDER 1 0.0001
816 BACK INJURY 1 0.0001
817 CHEST PAIN 17 0.0001
818 TREATMENT NONCOMPLIANCE 5 0.0001
819 BACK PAIN 21 0.0001
820 RASH MACULO-PAPULAR 2 0.0001
821 ADVERSE DRUG REACTION 8 0.0001
822 ANGER 3 0.0001
823 DEPRESSION 20 0.0001
824 PRODUCT AVAILABILITY ISSUE 2 0.0001
825 CHOLECYSTECTOMY 1 0.0001
826 FATIGUE 67 0.0001
827 RENAL DISORDER 4 0.0001
828 CARDIAC DISORDER 8 0.0001
829 HEART RATE DECREASED 3 0.0001
830 PALPITATIONS 10 0.0001
831 INFLUENZA LIKE ILLNESS 7 0.0001
832 BLOOD IRON DECREASED 1 0.0001
833 BACTERAEMIA 1 0.0001
834 HEPATIC CANCER 2 0.0001
835 PRESYNCOPE 2 0.0001
836 LIVER INJURY 2 0.0001
837 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
838 HYPERTENSION 17 0.0001
839 AGEUSIA 2 0.0001
840 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
841 DEVICE ISSUE 7 0.0001
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
843 NERVOUSNESS 4 0.0001
844 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
845 DIZZINESS 38 0.0001
846 ANHEDONIA 2 0.0001
847 BLOOD PRESSURE DECREASED 5 0.0001
848 WEIGHT DECREASED 21 0.0001
849 INJECTION SITE HAEMORRHAGE 6 0.0001
850 DIARRHOEA 48 0.0001
851 FEAR 2 0.0001
852 DYSPHAGIA 7 0.0001
853 PALLOR 2 0.0001
854 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
855 PROCEDURAL PAIN 2 0.0001
856 HAEMOPTYSIS 2 0.0001
857 APHONIA 1 0.0001
858 CARPAL TUNNEL SYNDROME 1 0.0001
859 BLOOD TEST ABNORMAL 1 0.0001
860 DEVICE OCCLUSION 1 0.0001
861 PNEUMONIA 23 0.0001
862 NAUSEA 56 0.0001
863 PAIN IN JAW 2 0.0001
864 MYALGIA 12 0.0001
865 RHEUMATOID ARTHRITIS 8 0.0001
866 VOMITING 33 0.0001
867 BRONCHOSPASM 1 0.0001
868 SYNCOPE 7 0.0001
869 SEIZURE 8 0.0001
870 PANCREATIC CARCINOMA 2 0.0001
871 LIVER DISORDER 3 0.0001
872 DYSGEUSIA 5 0.0001
873 COLITIS ULCERATIVE 3 0.0001
874 THROAT IRRITATION 3 0.0001
875 CHRONIC KIDNEY DISEASE 5 0.0001
876 NEPHROLITHIASIS 3 0.0001
877 MUSCLE SPASMS 12 0.0001
878 DEVICE RELATED INFECTION 1 0.0001
879 DELUSION 1 0.0001
880 BLOOD CHOLESTEROL INCREASED 3 0.0001
881 COGNITIVE DISORDER 3 0.0001
882 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
883 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
884 NERVOUS SYSTEM DISORDER 2 0.0001
885 NEUROPATHY PERIPHERAL 6 0.0001
886 ABSCESS 1 0.0001
887 CARDIAC FAILURE CONGESTIVE 5 0.0001
888 HIP FRACTURE 2 0.0001
889 PROSTATE CANCER 5 0.0001
890 NIGHT SWEATS 2 0.0001
891 CONFUSIONAL STATE 10 0.0001
892 DYSPNOEA 35 0.0001
893 DRY MOUTH 5 0.0001
894 VISUAL ACUITY REDUCED 2 0.0001
895 CANDIDA INFECTION 1 0.0001
896 BLOOD PRESSURE INCREASED 9 0.0001
897 DEVICE DEFECTIVE 1 0.0001
898 EOSINOPHILIA 1 0.0001
899 AMENORRHOEA 1 0.0001
900 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
901 ABDOMINAL PAIN 13 0.0001
902 BONE DISORDER 1 0.0001
903 PANIC ATTACK 2 0.0001
904 RESTLESSNESS 2 0.0001
905 SOMNOLENCE 11 0.0001
906 BLOOD GLUCOSE ABNORMAL 1 0.0001
907 BREAST CANCER 5 0.0001
908 INTESTINAL OBSTRUCTION 2 0.0001
909 FEELING JITTERY 1 0.0001
910 CHOKING 1 0.0001
911 ABORTION SPONTANEOUS 2 0.0000
912 EMOTIONAL DISTRESS 6 0.0000
913 DEVICE BREAKAGE 2 0.0000
914 VERTIGO 3 0.0000
915 LUNG NEOPLASM MALIGNANT 2 0.0000
916 ABDOMINAL PAIN UPPER 10 0.0000
917 DECREASED APPETITE 11 0.0000
918 CEREBROVASCULAR ACCIDENT 8 0.0000
919 AMNESIA 3 0.0000
920 DEVICE DISLOCATION 2 0.0000
921 MYOCARDIAL INFARCTION 8 0.0000
922 INFUSION RELATED REACTION 3 0.0000
923 ASTHENIA 17 0.0000
924 INJURY 3 0.0000
925 ARRHYTHMIA 2 0.0000
926 THERAPY INTERRUPTED 3 0.0000
927 MOBILITY DECREASED 3 0.0000
928 BLOOD PRESSURE FLUCTUATION 1 0.0000
929 BLOOD GLUCOSE DECREASED 2 0.0000
930 CONSTIPATION 9 0.0000
931 FLUSHING 4 0.0000
932 FLUID RETENTION 2 0.0000
933 LOSS OF CONSCIOUSNESS 5 0.0000
934 ERECTILE DYSFUNCTION 1 0.0000
935 DIPLOPIA 1 0.0000
936 RENAL FAILURE 5 0.0000
937 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
938 PLATELET COUNT DECREASED 4 0.0000
939 DEHYDRATION 5 0.0000
940 BLOOD GLUCOSE INCREASED 7 0.0000
941 DISTURBANCE IN ATTENTION 2 0.0000
942 HAEMATOCHEZIA 2 0.0000
943 FEELING COLD 1 0.0000
944 RENAL IMPAIRMENT 3 0.0000
945 MUSCULAR WEAKNESS 4 0.0000
946 ANGINA PECTORIS 1 0.0000
947 DYSSTASIA 1 0.0000
948 BONE PAIN 2 0.0000
949 ACUTE MYOCARDIAL INFARCTION 1 0.0000
950 DISEASE PROGRESSION 4 0.0000
951 JOINT SWELLING 4 0.0000
952 DRUG ADMINISTRATION ERROR 1 0.0000
953 ADVERSE EVENT 3 0.0000
954 PULMONARY EMBOLISM 3 0.0000
955 DEVICE EXPULSION 2 0.0000
956 DEEP VEIN THROMBOSIS 2 0.0000
957 DYSPEPSIA 3 0.0000
958 DRUG DOSE OMISSION 5 0.0000
959 HYPOTENSION 6 0.0000
960 AGITATION 2 0.0000
961 DYSURIA 1 0.0000
962 SEPSIS 3 0.0000
963 DYSARTHRIA 1 0.0000
964 COLITIS 1 0.0000
965 ACUTE KIDNEY INJURY 4 0.0000
966 HOSPITALISATION 4 0.0000
967 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
968 ABNORMAL BEHAVIOUR 1 0.0000
969 DISORIENTATION 1 0.0000
970 DRUG INTERACTION 4 0.0000
971 THROMBOSIS 2 0.0000
972 OEDEMA PERIPHERAL 3 0.0000
973 DYSKINESIA 1 0.0000
974 DEATH 20 0.0000
975 BALANCE DISORDER 2 0.0000
976 DEVICE LEAKAGE 1 0.0000
977 TACHYCARDIA 2 0.0000
978 SUICIDAL IDEATION 2 0.0000
979 COMA 1 0.0000
980 ANAEMIA 4 0.0000
981 AGGRESSION 1 0.0000
982 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
983 DEVICE DIFFICULT TO USE 1 0.0000
984 FEBRILE NEUTROPENIA 1 0.0000
985 DEVICE MALFUNCTION 1 0.0000
986 DRUG DEPENDENCE 2 0.0000
987 CARDIAC ARREST 1 0.0000
988 OVERDOSE 2 0.0000